FACEIT recently revealed Minerva, their AI which challenges toxicity in their CSGO servers – and it’s already proving successful.
FACEIT deployed their new AI in August and has since read 200,000,000 messages to check for toxicity.
In collaboration with Jigsaw, a google technology incubator and the Google Cloud, Minerva will learn what toxicity is, and how severe toxic messages are.
If Minerva detects an account being toxic in-game, the AI will issue notifications to the culprit after the game ends.
These notifications initially start as warnings, but further toxicity activates a 24-hour queue ban, with extensions made for repeat offenders.
In addition, Minerva can also put accounts on cooldown for inappropriate spam in-game.
Since Minerva’s launch in late August, over 20,000 bans have been issued to accounts due to toxic behaviour automatically.
Furthermore, Minerva issued 90,000 notifications for toxic behaviour and spam.
So far, FACEIT has seen a 20.13% drop in toxic messages since Minerva’s launch, with an 8% decrease in unique users displaying toxicity.
Lastly, FACEIT deployed an SMS verification system to reduce the potential of hackers, toxicity and smurf accounts, etc.
Thus far, 50,000 accounts have been blocked from participating in FACEIT services.
The need for it
The need for Minerva on FACEIT’s third-party software is necessary.
FACEIT operate across several titles, with hundreds of lobbies launching hourly.
It is impossible to have admins police these games to cut down on severe toxic offenders.
Since testing began, the AI has read 200,000,000 messages and deemed 7,000,000 of them as toxic.
The reach Minerva has over human administration is already proving more efficient and results in better responses to toxic behaviour on their servers.
Jigsaw released a case study talking about the importance of AI tackling negative comments.
The case study raises the issue of responding to toxicity in a timely manner, which explains the need to develop software such as Minerva.
FACEIT will announce more news on Minerva as they continue its development.